Asked by: Steve Yemm (Labour - Mansfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when he expects treatments for fatty liver disease to be approved for use on the NHS; what assessment he has made of the readiness of the NHS to make such treatments available; and what steps he is taking to ensure eligible patients will receive these treatments once approved.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), which is the independent body responsible for developing evidence-based guidance for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. NICE aims wherever possible to issue draft guidance on new medicines close to the time of licensing. The NHS in England is legally required to fund drugs recommended by NICE, usually within three months of final guidance.
NICE is currently evaluating potential new treatments for metabolic dysfunction-associated steatohepatitis (MASH) in anticipation of the medicines being granted a marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) with guidance expected later this year. NHS England is actively preparing to support the potential introduction of new treatments for MASH, including fatty liver disease with fibrosis, alongside the ongoing NICE appraisal process.
The Department and NHS England will continue to work to ensure that, once approved, effective new treatments for fatty liver disease are introduced in a way that is fair, affordable and protects the wider NHS, while ensuring that patients with the greatest clinical need are able to benefit as quickly as possible.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support earlier diagnosis of Type 1 Diabetes in babies, toddlers and children presenting with symptoms in primary care in Surrey Heath constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Local health commissioners and providers in Surrey are responsible for assessing how existing clinical guidance is being applied across primary care settings.
NHS England is undertaking a review of options for supporting primary care services in the identification of acute onset Type 1 diabetes in babies and children and in doing so will engage with relevant national organisations and partners.
As set out in the 10-Year Health Plan for England, we will continue to support people living with diabetes, including through the rollout of new wearable technologies such as hybrid closed loop (HCL) systems. The rollout of HCL systems is backed by £107 million in 2026/27 and has been made available to over 23,000 additional people since 2023/24.
Asked by: Maureen Burke (Labour - Glasgow North East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has had recent discussions with Marie Curie on funding for the hospice sector.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Last year, I met key palliative care and end-of-life care stakeholders, including Marie Curie, in a roundtable format with a focus on long-term sector sustainability within the context of our 10-Year Health Plan.
The Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England, and we will consider contracting and commissioning arrangements as part of this work. We recognise that there is currently a mix of contracting models in the hospice sector. By supporting integrated care boards to commission more strategically, we can move away from grant and block contract models. In the long term, this will aid sustainability and help hospices’ ability to plan ahead.
Officials are working closely with Marie Curie and a number of other stakeholders from the hospice sector in the development of the MSF.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will take steps to increase the number of places for domestic students on medical courses in universities.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
In England, the Office for Students (OfS) sets the maximum fundable limit for medical school places on an annual basis. OfS will publish its intake target for the 2026/27 academic year in due course.
For the 2025/26 academic year, OfS has published its intake target at 8,126 for medical school places, with further information available at the following link:
On 28 January, the Medical Training (Prioritisation) Bill was introduced in the House of Lords. This bill implements the Government’s commitment in the 10-Year Health Plan to prioritise UK medical graduates for foundation training places, and to prioritise UK medical graduates and other doctors with significant NHS experience for specialty places.
Asked by: Mike Wood (Conservative - Kingswinford and South Staffordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 11 December 2025 to Question 94707 on Department of Health and Social Care and NHS England: Flags, if he will list each flag, for flying from buildings that his Department hold.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department holds a range of flags including the National Health Service flag and the commonwealth flag that are flown when instructed to by the Department for Culture, Media and Sport. The Union flag is flown the majority of the year.
Asked by: Jack Rankin (Conservative - Windsor)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of vaping devices that (a) contain and (b) can be configured to contain more than the standard 2ml tank capacity through (i) interchangeable and (ii) modular components on public health.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Tobacco and Vapes Bill will stop vapes and nicotine products from being deliberately branded, promoted, and advertised to children and provides the Government with new powers to restrict the packaging, device appearance, and display of vapes and other nicotine products to stop the next generation from becoming hooked on nicotine.
On 8 October 2025, we launched a Call for Evidence which sought evidence on the size and shape of vapes, vape tanks, and the components of vaping products, including pods, puff-count capacity, and nicotine delivery.
We are now reviewing the responses, and these will help inform decisions around our future regulatory approach once the Tobacco and Vapes Bill has been enacted.
The Department for Environment, Food and Rural Affairs, as part of their upcoming Circular Economy Growth Plan, will consider evidence across a range of interventions, including but not limited to the regulation of product features to support increased recyclability.
Asked by: Andrew Snowden (Conservative - Fylde)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what oversight mechanisms were in place within NHS England and his Department to monitor the expenditure and governance of overseas medical training schemes operated by NHS trusts.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
There are a variety of international postgraduate medical training schemes in operation governed by individual National Health Service trusts, medical royal colleges, the Academy of Medical Royal Colleges and indirectly, NHS England and the General Medical Council. These programmes must be properly governed, deliver value for money, and treat all participants fairly. We expect all NHS organisations to operate in line with these principles.
The Medical Training (Prioritisation) Bill was introduced to Parliament on 13 January 2026. The bill delivers the Government’s commitment in the 10-Year Health Plan for England, published in July 2025, to prioritise United Kingdom medical graduates for foundation training, and to prioritise UK medical graduates, and other doctors who have worked in the NHS for a significant period, for specialty training.
The 10 Year Workforce Plan will ensure the NHS has the right people in the right places, with the right skills to care for patients when they need it. As part of that plan, we will outline strategies for improving retention, productivity, training, and reducing attrition, enhancing conditions for all staff while gradually reducing reliance on international recruitment, without diminishing the value of their contributions.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many doctors have had to file an estimate for their tax returns as a result of not receiving the appropriate Pension Savings Statements before 31 January 2026.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Luke Evans (Conservative - Hinckley and Bosworth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what his planned timetable is for issuing Pension Savings Statements to doctors.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Mike Martin (Liberal Democrat - Tunbridge Wells)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to extend NHS eligibility for the Shingrix shingles vaccine to older adults who previously received Zostavax.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent departmental expert committee which advises the Government on matters related to vaccination and immunisation.
In November 2024, the JCVI provided advice to the Government on eligibility for the shingles vaccination programme. This included advice that the Government should consider expanding the shingles vaccination offer to include older adult cohorts aged 80 years old and over, regardless of whether these older individuals have previously been eligible for, or have been vaccinated with, Zostavax. The Department is carefully considering this advice as it sets the policy on who should be offered shingles vaccinations.